NBOG (Notified Bodies Operations Group) failure would reignite Euro MDA (Medical Devices Agency) talks:
This article was originally published in Clinica
Executive Summary
Strong support was expressed by delegates at the UK Medical Devices Agency's (MDA) update meeting on June 27 for the Notified Bodies Operations Group. If it fails in its objective of improving the monitoring and performance of notified bodies, some fear there would be renewed pressure for a European medical devices agency or a type of European FDA to police standards. The MDA is confident that it has the support of the other EU competent authorities driving the group forward, although it recognises that there is a fundamental resource problem in some countries which will need addressing.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.